No.

Publication Date

Citing Article

1

2024

Saru Basnet, Mirte Van der Heijden, Dafne C.A. Quixabeira, Elise Jirovec, Susanna A.M. Grönberg-Vähä-Koskela, James H.A. Clubb, Anna Kanerva, Santeri Pakola, Lyna Haybout, Victor Arias, Otto Hemminki, Tatiana Kudling, Sadia Zafar, Victor Cervera-Carrascon, Joao M. Santos, Akseli Hemminki. Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine, Molecular Therapy. 2024; 32: 3114.  https://doi.org/10.1016/j.ymthe.2024.06.029

2

2023

In Kang, Yumin Kim, Heung Kyu Lee. γδ T cells as a potential therapeutic agent for glioblastoma, Frontiers in Immunology. 2023; 14: 1273986.  https://doi.org/10.3389/fimmu.2023.1273986

3

2024

Noah Eckman, Anahita Nejatfard, Romola Cavet, Abigail K. Grosskopf, Eric A. Appel. Biomaterials to enhance adoptive cell therapy, Nature Reviews Bioengineering. 2024; 2: 408.  https://doi.org/10.1038/s44222-023-00148-z

4

2024

Ngoc Thien Thu Nguyen, Rasmus Müller, Daria Briukhovetska, Justus Weber, Judith Feucht, Annette Künkele, Michael Hudecek, Sebastian Kobold. The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity, Cancers. 2024; 16: 2608.  https://doi.org/10.3390/cancers16142608

5

2023

Ying Fang, Yichen Zhu, Adam Kramer, Yuning Chen, Yan-Ruide Li, Lili Yang. Graft-versus-Host Disease Modulation by Innate T Cells, International Journal of Molecular Sciences. 2023; 24: 4084.  https://doi.org/10.3390/ijms24044084

6

2024

W.K. Lim, N.G. Iyer. A GD Type of Cancel Culture, Immuno-Oncology and Technology. 2024; 24: 100740100740.  https://doi.org/10.1016/j.iotech.2024.100740

7

2025

Caroline Diorio, David T. Teachey, Stephan A. Grupp. Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks, Nature Reviews Clinical Oncology. 2025; 22: 10.  https://doi.org/10.1038/s41571-024-00959-y

8

2024

Joanna Chojnacka-Purpurowicz, Agnieszka Owczarczyk-Saczonek, Bogusław Nedoszytko. The Role of Gamma Delta T Lymphocytes in Physiological and Pathological Condition—Focus on Psoriasis, Atopic Dermatitis, Autoimmune Disorders, Cancer and Lymphomas, International Journal of Molecular Sciences. 2024; 25: 7960.  https://doi.org/10.3390/ijms25147960

9

2022

Marta Sanz, Brendan T. Mann, Alisha Chitrakar, Natalia Soriano-Sarabia. Human Vδ2 T Cells and Their Versatility for Immunotherapeutic Approaches, Cells. 2022; 11: 3572.  https://doi.org/10.3390/cells11223572

10

2023

Léa Rimailho, Carla Faria, Marcin Domagala, Camille Laurent, Christine Bezombes, Mary Poupot. γδ T cells in immunotherapies for B-cell malignancies, Frontiers in Immunology. 2023; 14: 1200003.  https://doi.org/10.3389/fimmu.2023.1200003

11

2024

Sridevi Rajeeve, Abhinav Hoskote, Sham Mailankody. Accelerating accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?, Seminars in Hematology. 2024; 61: 297.  https://doi.org/10.1053/j.seminhematol.2024.09.001

12

2025

M. Velasco Santiago, P. Aehnlich, T.M. Hulen, K.M. Jensen, G. Holmen Olofsson, Ö. Met, P. thor Straten. Overcoming antigen loss in CAR T therapy with Vγ9Vδ2 CAR T-cells, Immuno-Oncology and Technology. 2025; 26: 101053101053.  https://doi.org/10.1016/j.iotech.2025.101053

13

2025

Ana María Múnera-Rodríguez, Camila Leiva-Castro, Pedro Chacón, Francisca Palomares, Soledad López-Enríquez. 2025;   https://doi.org/10.1016/bs.ircmb.2025.03.006

14

2024

Jiapei Yuan, Jingliao Zhang, Beibei Zhao, Fang Liu, Tianfeng Liu, Yongjuan Duan, Yumei Chen, Xiaojuan Chen, Yao Zou, Li Zhang, Ye Guo, Wenyu Yang, Yang Yang, Jun Wei, Xiaofan Zhu, Yingchi Zhang. Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemia, Cancer Letters. 2024; 596: 217018217018.  https://doi.org/10.1016/j.canlet.2024.217018

15

2022

Rama Rao Malla, Priyamvada Bhamidipati. γδ T Cell-Mediated Immune Responses for Cancer Therapy: Special Focus on Breast Cancer , Critical Reviews in Immunology. 2022; 42: 9.  https://doi.org/10.1615/CritRevImmunol.2023047363

16

2024

Georg Schett, Fabian Müller, Jule Taubmann, Andreas Mackensen, Wei Wang, Rich A. Furie, Ralf Gold, Aiden Haghikia, Peter A. Merkel, Roberto Caricchio, Maria-Antonietta D’Agostino, Franco Locatelli, Carl H. June, Dimitrios Mougiakakos. Advancements and challenges in CAR T cell therapy in autoimmune diseases, Nature Reviews Rheumatology. 2024; 20: 531.  https://doi.org/10.1038/s41584-024-01139-z

17

2023

Derek Lee, Zachary Spencer Dunn, Wenbin Guo, Carl J. Rosenthal, Natalie E. Penn, Yanqi Yu, Kuangyi Zhou, Zhe Li, Feiyang Ma, Miao Li, Tsun-Ching Song, Xinjian Cen, Yan-Ruide Li, Jin J. Zhou, Matteo Pellegrini, Pin Wang, Lili Yang. Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering, Nature Communications. 2023; 14: 6942.  https://doi.org/10.1038/s41467-023-42619-2

18

2024

Andrew P Jallouk, Salyka Sengsayadeth, Bipin N Savani, Bhagirathbhai Dholaria, Olalekan Oluwole. Allogeneic and other innovative chimeric antigen receptor platforms, Clinical Hematology International. 2024; 6:   https://doi.org/10.46989/001c.121404

19

2024

Christophe Richez, CAR-T cell en rhumatologie, Revue du Rhumatisme. 2024; 91: A8.  https://doi.org/10.1016/j.rhum.2024.10.003

20

2024

Adishwar Rao, Akriti Agrawal, Gautam Borthakur, Venkata Lokesh Battula, Abhishek Maiti. Gamma delta T cells in acute myeloid leukemia: biology and emerging therapeutic strategies, Journal for ImmunoTherapy of Cancer. 2024; 12: e007981.  https://doi.org/10.1136/jitc-2023-007981

21

2023

Claudia Giannotta, Federica Autino, Massimo Massaia. Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?, Frontiers in Immunology. 2023; 14: 1167443.  https://doi.org/10.3389/fimmu.2023.1167443

22

2024

Pin Yao, Ya-Guang Liu, Gang Huang, Liangchun Hao, Runan Wang. The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances, Experimental Hematology & Oncology. 2024; 13: 118.  https://doi.org/10.1186/s40164-024-00583-7

23

2024

Ekaterina Pashkina, Elena Blinova, Maria Bykova, Alina Aktanova, Vera Denisova. Cell Therapy as a Way to Increase the Effectiveness of Hematopoietic Stem Cell Transplantation, Cells. 2024; 13: 2056.  https://doi.org/10.3390/cells13242056

24

2024

Megan Yuan, Wenjun Wang, Isobel Hawes, Junwen Han, Zhenyu Yao, Alice Bertaina. Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy, Frontiers in Immunology. 2024; 15: 1360237.  https://doi.org/10.3389/fimmu.2024.1360237

25

2024

Caroline Lonez, Eytan Breman. Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?, Cells. 2024; 13: 146.  https://doi.org/10.3390/cells13020146

26

2025

Sylwia Biały, Katarzyna Bogunia-Kubik. Uncovering the mysteries of human gamma delta T cells: from origins to novel therapeutics, Frontiers in Immunology. 2025; 16: 1543454.  https://doi.org/10.3389/fimmu.2025.1543454

27

2023

John Anderson, Marta Barisa. Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers, Molecular Therapy - Oncolytics. 2023; 30: 151.  https://doi.org/10.1016/j.omto.2023.08.003